Status:
COMPLETED
Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.
Lead Sponsor:
Melbourne Health
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-88 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate whether fish oil supplements may reduce the frequency and duration of paroxysmal atrial fibrillation episodes. Atrial fibrillation is a heart condition whi...
Eligibility Criteria
Inclusion
- Patients who have had at least 2 previous episodes of atrial fibrillation and an implanted pacemaker.
Exclusion
- Patients with chronic atrial fibrillation
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00232245
Start Date
December 1 2003
End Date
January 1 2013
Last Update
May 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Melbourne hospital
Melbourne, Victoria, Australia, 3050